|
Video: Compound Annual Growth Rate (CAGR) Definition
|
|
Date |
Open |
High |
Low |
Close |
Volume |
01/16/2025 |
$2.64 |
$2.64 |
$2.44 |
$2.46 |
187.70K | 01/17/2025 |
$2.48 |
$2.50 |
$2.38 |
$2.40 |
238.50K | 01/21/2025 |
$2.41 |
$2.45 |
$2.31 |
$2.37 |
383.80K | 01/22/2025 |
$2.37 |
$2.59 |
$2.35 |
$2.52 |
351.50K | 01/23/2025 |
$2.53 |
$2.57 |
$2.46 |
$2.56 |
125.70K |
|
TScan Therapeutics, Inc. is a clinical-stage biopharmaceutical company. Co. is focused on developing a pipeline of T cell receptor-engineered T cell (TCR-T), therapies for the treatment of patients with cancer. Co.'s lead TCR-T therapy candidates, TSC-100 and TSC-101, are in clinical development for the treatment of patients with hematologic malignancies to eliminate residual disease and prevent relapse after allogeneic hematopoietic cell transplantation. Co. is also developing multiplexed TCR-T therapy candidates for the treatment of various solid tumors. | |
|
TScan Therapeutics (TCRX) has the following price history information. Looking back at TCRX historical stock prices for the last five trading days, on January 16, 2025, TCRX opened at $2.64, traded as high as $2.64 and as low as $2.44, and closed at $2.46. Trading volume was a total of 187.70K shares. On January 17, 2025, TCRX opened at $2.48, traded as high as $2.50 and as low as $2.38, and closed at $2.40. Trading volume was a total of 238.50K shares. On January 21, 2025, TCRX opened at $2.41, traded as high as $2.45 and as low as $2.31, and closed at $2.37. Trading volume was a total of 383.80K shares. On January 22, 2025, TCRX opened at $2.37, traded as high as $2.59 and as low as $2.35, and closed at $2.52. Trading volume was a total of 351.50K shares. On January 23, 2025, TCRX opened at $2.53, traded as high as $2.57 and as low as $2.46, and closed at $2.56. Trading volume was a total of 125.70K shares.
TCRX Historical Stock Prices By Date:
Below, we examine the compound annual growth rate — CAGR for short — of an investment into TScan Therapeutics shares, starting with a $10,000 purchase of TCRX, and working forward through the historical stock price information to today.
Growth of $10,000.00
Without Dividends Reinvested
|
Start date: |
07/19/2021 |
|
End date: |
01/23/2025 |
|
Start price/share: |
$10.01 |
|
End price/share: |
$2.56 |
|
Dividends collected/share: |
$0.00 |
|
Total return: |
-74.43% |
|
Average Annual Total Return: |
-32.13% |
|
Starting investment: |
$10,000.00 |
|
Ending investment: |
$2,557.85 |
|
Years: |
3.52 |
|
|
|
Date |
Close |
01/16/2025 | $2.46 | 01/17/2025 | $2.40 | 01/21/2025 | $2.37 | 01/22/2025 | $2.52 | 01/23/2025 | $2.56 |
|
|